{
    "2020-01-22": [
        [
            {
                "time": "2020-01-22",
                "original_text": "中国光大银行2019年归母净利373.54亿元 同比增10.98%",
                "features": {
                    "keywords": [
                        "中国光大银行",
                        "归母净利",
                        "同比增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-22",
                "original_text": "复星医药(SAF-189)治疗肿瘤的临床试验获美国FDA批准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "SAF-189",
                        "肿瘤",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-01-22",
                "original_text": "*ST信威预亏167亿元，可能被暂停上市",
                "features": {
                    "keywords": [
                        "*ST信威",
                        "预亏",
                        "暂停上市"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "通信"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-01-22",
                "original_text": "A股发生81宗大宗交易 成交21.97亿元",
                "features": {
                    "keywords": [
                        "A股",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-01-22",
                "original_text": "复星医药新药“丁二酸复瑞替尼”获“美国FDA”批准临床试验",
                "features": {
                    "keywords": [
                        "复星医药",
                        "丁二酸复瑞替尼",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-01-22",
                "original_text": "复星医药今日大宗交易成交33.59万股，成交价25.07元折价7.35%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}